| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 74.7 | 65.6 | +13.9% |
| EBITDA | 14.4 | 11.9 | +20.6% |
| EBITDA margin | 19.2% | 18.2% | +1.1 pts |
| Profit before tax | 12.0 | 9.6 | +25.5% |
| Net profit | 10.3 | 8.3 | +23.8% |
| EPS | ₹1.87 | ₹1.53 | +22.2% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 |
|---|
| 997 | — | — | |
| 21.1 | 21.1 | 90.8 | |
| 0.8 | 0.8 | 0.2 | |
| 0.0 | 0.0 | 11.4 | |
| 977 | — | — | |
| 287 | 278 | 239 | |
| — | +16.2% | — | |
| 45.9 | 43.4 | 41.9 | |
| 16.0% | 15.6% | 17.5% | |
| 29.2 | 27.5 | 26.9 | |
| 30.9 | 28.9 | 31.8 | |
| 10.8% | 10.4% | 13.3% | |
| ₹5.62 | ₹5.27 | ₹5.78 | |
| — | −8.8% | — | |
| — | −5.0 | 43.8 | |
| — | −18.4 | −16.1 | |
| −23.4 | −23.4 | 27.8 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|
| Market Capitalization | — | — | 996.9 | |
| - Cash, Equiv & ST Investments | 90.8 | 21.1 | 21.1 | |
| + Minority Interest | 0.2 | 0.8 | 0.8 | |
| + Total Debt | 11.4 | 0.0 | 0.0 | |
| Enterprise Value | — | — | 976.6 | |
| Revenue | 239.1 | 277.9 | 287.0 | |
| Growth %, YoY | — | +16.2 | — | |
| EBITDA | 41.9 | 43.4 | 45.9 | |
| Margin % | 17.51 | 15.62 | 15.98 | |
| EBIT | 26.9 | 27.5 | 29.2 | |
| Net Income | 31.8 | 28.9 | 30.9 | |
| Margin % | 13.31 | 10.41 | 10.77 | |
| EPS, Adj (current shares) | 5.78 | 5.27 | 5.62 | |
| Growth %, YoY | — | -8.8 | — | |
| Cash from Operations | 43.8 | -5.0 | — | |
| Capital Expenditures | -16.1 | -18.4 | — | |
| Free Cash Flow | 27.8 | -23.4 | -23.4 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Laxmi Dental (NSE: LAXMIDENTL) had a market capitalisation of ₹975 crore at the 29 October 2026 close (₹177.37 a share), a PE ratio of 31.6 on the last four quarters' profit and a price-to-book ratio of 4.01. In FY26 its consolidated net profit was ₹29 crore on revenue of ₹278 crore; in Q1 FY27 (April–June 2026) it was ₹10.3 crore, up 22.8% year on year. It had no borrowings on 31 March 2026. Promoters held 41.75% of the shares on 30 September 2026.
Laxmi Dental's PE ratio is 31.6 at the 29 October 2026 close (₹177.37 a share): a market capitalisation of ₹975 crore divided by consolidated net profit of ₹30.9 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹29 crore) it is 33.6.
Laxmi Dental's net worth — shareholders' equity in its consolidated balance sheet — was ₹243 crore on 31 March 2026, up 16.7% from ₹209 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹975 crore at the 29 October 2026 close.
Laxmi Dental's book value per share was ₹44.27 on 31 March 2026: shareholders' equity of ₹243 crore divided by the 5.5 crore shares in issue, up 16.7% from ₹37.94 a year earlier. The share price at the 29 October 2026 close was ₹177.37.
Laxmi Dental's price-to-book (PB) ratio is 4.01 at the 29 October 2026 close: a market capitalisation of ₹975 crore divided by shareholders' equity (book value) of ₹243 crore on 31 March 2026. That is a book value of ₹44.27 per share against a share price of ₹177.37.
In FY26, Laxmi Dental's return on equity (ROE) was 12.8% and its return on capital employed (ROCE) was 11.2%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).
Promoters held 41.75% of Laxmi Dental on 30 September 2026, down 0.05 percentage points from 41.80% the previous quarter and up 0.05 percentage points from 41.70% a year earlier, according to the shareholding pattern filed with NSE.
Laxmi Dental's market capitalisation was ₹975 crore at the 29 October 2026 close: 5.5 crore shares at ₹177.37 each.
Yes. Laxmi Dental had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹22.2 crore of cash, bank balances and current investments.
Laxmi Dental's debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹244 crore. A year earlier, on 31 March 2025, it was 0.05.
Laxmi Dental's basic earnings per share (EPS) were ₹5.53 in FY26, against ₹6.06 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹5.66.
In FY26, Laxmi Dental generated ₹5 crore of cash from operations and spent ₹18.4 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹23.4 crore. In FY25 it was ₹27.8 crore.
Laxmi Dental will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.
On 30 September 2026, Laxmi Dental's shares were held by promoters 41.75%, foreign portfolio investors (FII/FPI) 6.58%, domestic institutions (DII) 10.68% (including mutual funds at 9.77%) and retail and other non-institutional investors 41.00%. Over the year, FII holding was down 25.81 percentage points from 32.39% and DII holding was down 1.17 percentage points from 11.85%.
Laxmi Dental's latest results are for Q1 FY27 (April–June 2026), filed on 11 August 2026: consolidated net profit ₹10.3 crore, up 22.8% from ₹8.4 crore in Q1 FY26; revenue from operations ₹74.7 crore, up 13.9% year on year.
At the 29 October 2026 closing prices, on FY26 net profit, Laxmi Dental's PE ratio is 33.6, the third highest of the four: Fabtech Technologies 14.2, Tarsons Products 112.9 and Fischer Medical Ventures 54.7, a peer average of 60.6. Each is the company's market capitalisation at that price divided by its FY26 net profit.
In FY26 (April 2025–March 2026), Laxmi Dental's consolidated net profit was ₹29 crore, down 8.8% from ₹31.8 crore in FY25, on revenue from operations of ₹278 crore (up 16.2%).
On FY26 consolidated figures, against Fabtech Technologies, Tarsons Products and Fischer Medical Ventures: Laxmi Dental's operating margin of 9.9% is the second highest of the four (Fabtech Technologies 7.2%, Tarsons Products 5.1%, Fischer Medical Ventures 13.0%; peer average 8.4%); its return on equity of 12.8% is the highest of the four (Fabtech Technologies 9.1%, Tarsons Products 2.3%, Fischer Medical Ventures 8.1%; peer average 6.5%).
In FY26, Laxmi Dental earned net profit of ₹29 crore on revenue of ₹278 crore, against ₹38.4 crore on ₹411 crore for Fabtech Technologies. Laxmi Dental's operating margin was 9.9% (Fabtech Technologies 7.2%) and its return on equity 12.8% (Fabtech Technologies 9.1%). At the 29 October 2026 close, Laxmi Dental's market capitalisation was ₹975 crore against ₹543 crore for Fabtech Technologies, and its PE ratio on FY26 profit 33.6 against 14.2.
From Laxmi Dental's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.